Period of time： 2013年2期
Publisher： Informa Healthcare
Founded in： 2008
Total resources： 4
ISSN： 1747-4086
Subject： R3 Basic Medical
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Expert Review of Hematology,volume 6,issue 2
Menu
Factor XI and traveling waves: the key to understanding coagulation in hemophilia?
By Ataullakhanov Fazoil I,Dashkevich Natalia M,Negrier Claude,Panteleev Mikhail A in (2013)
Expert Review of Hematology,volume 6,issue 2 , Vol. 6, Iss. 2, 2013-04 , pp.
Access to resources
Recommend
Could statins be a new therapeutic option for antiphospholipid syndrome patients?
By Erkan Doruk,Pierangeli Silvia S in (2013)
Expert Review of Hematology,volume 6,issue 2 , Vol. 6, Iss. 2, 2013-04 , pp.Bendamustine for non-Hodgkin lymphoma
Expert Review of Hematology,volume 6,issue 2 , Vol. 6, Iss. 2, 2013-04 , pp.By Shadman Mazyar,Estey Elihu H in (2013)
Expert Review of Hematology,volume 6,issue 2 , Vol. 6, Iss. 2, 2013-04 , pp.Low-molecular-weight heparin versus rivaroxaban in orthopedic surgery
Expert Review of Hematology,volume 6,issue 2 , Vol. 6, Iss. 2, 2013-04 , pp.Atypical lymphoid proliferations: the pathologist's viewpoint
By Hussein Mahmoud Rezk Abdelwahed in (2013)
Expert Review of Hematology,volume 6,issue 2 , Vol. 6, Iss. 2, 2013-04 , pp.Monitoring plasma levels of factor Xa inhibitors: how, why and when?
By Samama Meyer-Michel,Amiral Jean,Guinet Céline,Flem Léna Le,Seghatchian Jerard in (2013)
Expert Review of Hematology,volume 6,issue 2 , Vol. 6, Iss. 2, 2013-04 , pp.Review of therapeutic options and the management of patients with myelodysplastic syndromes
By Özcan Mehmet A,Ilhan Osman,Ozcebe Osman I,Nalcaci Meliha,Gülbas Zafer in (2013)
Expert Review of Hematology,volume 6,issue 2 , Vol. 6, Iss. 2, 2013-04 , pp.
Previous
Next